WINT - Windtree Therapeutics Stock Price, News & Analysis

$0.39 0.05 (14.71 %)
(As of 11/23/2017 08:03 AM ET)
Previous Close$0.34
Today's Range$0.34 - $0.39
52-Week Range$0.18 - $1.85
Volume25,641 shs
Average Volume127,708 shs
Market Capitalization$4.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

About Windtree Therapeutics (OTCMKTS:WINT)

Windtree Therapeutics logoWindtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The Company's technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant, and drug delivery technologies being developed to enable non-invasive administration of aerosolized KL4 surfactant. The Company's core development program, AEROSURF (lucinactant for inhalation), is focused on improving the management of respiratory distress syndrome (RDS) in premature infants, a respiratory condition that can result in long-term respiratory problems, developmental delay and death.


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryBiotechnology
SectorMedical
SymbolOTCMKTS:WINT
  • Previous Symbol: NASDAQ:WINT
  • CUSIP25466840

    Debt

    Debt-to-Equity Ratio-0.33%
    Current Ratio0.10%
    Quick Ratio0.10%

    Price-To-Earnings

    Trailing P/E RatioN/A
    Forward P/E RatioN/A
    P/E GrowthN/A

    Sales & Book Value

    Annual Sales$2.04 million
    Price / Sales2.67
    Cash FlowN/A
    Price / CashN/A
    Book Value($2.68) per share
    Price / Book-0.15

    Dividend

    Annual DividendN/A
    Dividend YieldN/A

    Profitability

    Trailing EPS($3.59)
    Net Income$-39,490,000.00
    Net Margins-1,205.47%
    Return on EquityN/A
    Return on Assets-345.52%

    Miscellaneous

    Employees49
    Outstanding Shares13,990,000

    Frequently Asked Questions for Windtree Therapeutics (OTCMKTS:WINT)

    What is Windtree Therapeutics' stock symbol?

    Windtree Therapeutics trades on the OTCMKTS under the ticker symbol "WINT."

    How were Windtree Therapeutics' earnings last quarter?

    Windtree Therapeutics, Inc. (OTCMKTS:WINT) posted its quarterly earnings data on Monday, August, 21st. The biotechnology company reported ($0.76) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.99) by $0.23. The biotechnology company had revenue of $1.15 million for the quarter, compared to analysts' expectations of $0.40 million. View Windtree Therapeutics' Earnings History.

    Who are some of Windtree Therapeutics' key competitors?

    Who are Windtree Therapeutics' key executives?

    Windtree Therapeutics' management team includes the folowing people:

    • John R. Leone, Independent Chairman of the Board (Age 67)
    • Craig Fraser, President, Chief Executive Officer, Director (Age 51)
    • John A. Tattory, Chief Financial Officer, Senior Vice President (Age 49)
    • Mary B. Templeton Esq., Senior Vice President, General Counsel and Corporate Secretary (Age 68)
    • Kathryn A. Cole, Senior Vice President - Human Resources (Age 49)
    • Steven G. Simonson M.D., Senior Vice President and Chief Development Officer (Age 56)
    • William C. Roberts, Vice President - Investor Relations and Corporate Communications (Age 45)
    • Michael L. Magee, Vice President - Technical Operations (Age 54)
    • Mahady M. Joseph, Independent Director (Age 63)
    • Bruce A. Peacock, Independent Director (Age 65)

    How do I buy Windtree Therapeutics stock?

    Shares of Windtree Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is Windtree Therapeutics' stock price today?

    One share of Windtree Therapeutics stock can currently be purchased for approximately $0.39.

    How big of a company is Windtree Therapeutics?

    Windtree Therapeutics has a market capitalization of $4.77 million and generates $2.04 million in revenue each year. The biotechnology company earns $-39,490,000.00 in net income (profit) each year or ($3.59) on an earnings per share basis. Windtree Therapeutics employs 49 workers across the globe.

    How can I contact Windtree Therapeutics?

    Windtree Therapeutics' mailing address is 2600 KELLY ROAD SUITE 100, WARRINGTON PA, 18976. The biotechnology company can be reached via phone at 215-488-9300 or via email at [email protected]


    MarketBeat Community Rating for Windtree Therapeutics (WINT)

    Community Ranking:  2.7 out of 5 (star star)
    Outperform Votes:  81 (Vote Outperform)
    Underperform Votes:  67 (Vote Underperform)
    Total Votes:  148
    MarketBeat's community ratings are surveys of what our community members think about Windtree Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for Windtree Therapeutics (OTCMKTS:WINT)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 0 Buy Ratings, 0 Strong Buy Ratings
    Consensus Rating:Hold (Score: 2.00)
    Analysts' Consensus Price Target: N/A

    Consensus Price Target History for Windtree Therapeutics (OTCMKTS:WINT)

    Price Target History for Windtree Therapeutics (OTCMKTS:WINT)

    Analysts' Ratings History for Windtree Therapeutics (OTCMKTS:WINT)

    Show:
    DateFirmActionRatingPrice TargetDetails
    6/30/2017Stifel NicolausDowngradeBuy -> HoldView Rating Details
    10/30/2016HC WainwrightSet Price TargetBuy$8.00View Rating Details
    (Data available from 11/23/2015 forward)

    Earnings

    Earnings History and Estimates Chart for Windtree Therapeutics (OTCMKTS:WINT)

    Earnings by Quarter for Windtree Therapeutics (OTCMKTS:WINT)

    Earnings History by Quarter for Windtree Therapeutics (OTCMKTS WINT)

    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    8/21/2017Q2 2017($0.99)($0.76)$0.40 million$1.15 millionViewN/AView Earnings Details
    5/15/2017Q1 2017($1.37)$0.22 millionViewN/AView Earnings Details
    8/10/2016Q2($1.64)($1.29)$0.08 million$0.11 millionViewN/AView Earnings Details
    5/12/2016Q116($1.58)($1.70)$0.08 millionViewListenView Earnings Details
    3/24/2016Q4($0.70)($1.26)$0.07 million$0.66 millionViewListenView Earnings Details
    8/10/2015Q215($0.13)($0.13)$0.45 million$0.08 millionViewListenView Earnings Details
    3/16/2015Q414($0.14)($0.12)$0.54 million$1.18 millionViewN/AView Earnings Details
    11/6/2014($0.15)($0.13)$0.50 million$0.53 millionViewN/AView Earnings Details
    8/5/2014Q2 14($0.15)($0.12)$0.26 million$1.09 millionViewN/AView Earnings Details
    5/8/2014Q114($0.13)($0.14)$2.69 million$0.03 millionViewN/AView Earnings Details
    3/13/2014Q413($0.16)($0.16)$0.36 million$0.07 millionViewN/AView Earnings Details
    11/12/2013Q3($0.20)($0.22)$0.11 millionViewListenView Earnings Details
    8/8/2013Q2 2013($0.28)($0.18)$10.00 million$0.18 millionViewN/AView Earnings Details
    11/8/2012Q312($0.23)($0.31)ViewN/AView Earnings Details
    (Data available from 1/1/2011 forward)

    Estimates

    Earnings Estimates for Windtree Therapeutics (OTCMKTS:WINT)

    No earnings estimates for this company have been tracked by MarketBeat.com

    Dividends

    Dividend History for Windtree Therapeutics (OTCMKTS:WINT)
    No dividend announcements for this company have been tracked by MarketBeat.com

    Insider Trades

    Insider Trading and Institutional Ownership History for Windtree Therapeutics (OTCMKTS WINT)

    Insider Ownership Percentage: 3.45%
    Institutional Ownership Percentage: 2.70%
    Insider Trades by Quarter for Windtree Therapeutics (OTCMKTS:WINT)
    Insider Trades by Quarter for Windtree Therapeutics (OTCMKTS:WINT)

    Insider Trades by Quarter for Windtree Therapeutics (OTCMKTS WINT)

    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    10/28/2016Craig FraserInsiderBuy7,500$2.05$15,375.00View SEC Filing  
    2/19/2013John R LeoneDirectorBuy3,000$2.88$8,640.00View SEC Filing  
    (Data available from 1/1/2013 forward)

    Headlines

    Latest Headlines for Windtree Therapeutics (OTCMKTS WINT)

    Source:
    DateHeadline
    Windtree Therapeutics Reports Third Quarter 2017 Financial ResultsWindtree Therapeutics Reports Third Quarter 2017 Financial Results
    finance.yahoo.com - November 16 at 7:53 AM
    Contrasting Windtree Therapeutics (WINT) & Its RivalsContrasting Windtree Therapeutics (WINT) & Its Rivals
    www.americanbankingnews.com - November 14 at 5:28 PM

    Social Media

    Financials

    Chart

    Windtree Therapeutics (OTCMKTS WINT) Chart for Thursday, November, 23, 2017
    Loading chart…

    This page was last updated on 11/23/2017 by MarketBeat.com Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.